Taro Pharmaceuticals to pay more than $200 mln to settle U.S. price-fixing probe

Taro Pharmaceutical Industries

23/07/2020 21:39

WASHINGTON, July 23 (Reuters) - Taro Pharmaceutical  TARO.N 
agreed to pay more than $200 million to settle allegations that
it conspired to fix the prices of generic drugs, the Justice
Department said on Thursday.

 (Reporting by Diane Bartz and Katanga Johnson
Editing by Chris Reese
Editing by Chris Reese)
 ((Katanga.Johnson@thomsonreuters.com; 202-898-8403; Reuters
Messaging: Katanga.Johnson.thomsonreuters.com@reuters.net))